Skip to main content
menu

Institute for Global Law, Economics and Finance

Illumina Faces Battle to Save Grail Deal From EU Veto

Professor Ioannis Kokkoris comments on the deal for Bloomberg.

Published:
A medical tester wearing PPE pouring liquid between test tubes

Ioannis Kokkoris, Professor of Competition Law and Economics; Dean for International, Faculty of Humanities and Social Sciences at Queen Mary University of London, spoke to Bloomberg about the battle Illumina Inc. faces to save its $8 billion bid for cancer-test provider Grail from a European Union veto ahead of a Friday deadline to allay antitrust concerns. Professor Kokkoris said: “There seems to be just one way forward for this which would be a break-up” of the business,. I don’t think a long-term behavioral access remedy will do it here,” he said, referring to the type of proposal made to U.S. watchdogs.

More information:

 

 

Return to top